Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-02
1996-11-12
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514326, 514338, 544238, 546209, 5462714, 546 15, 548232, A61K 3142
Patent
active
055740553
ABSTRACT:
The present invention relates to compounds of the formula: ##STR1## wherein R is H or alkyl;
REFERENCES:
patent: 3654298 (1972-04-01), Douzon et al.
patent: 4150029 (1979-04-01), Dostert et al.
patent: 4250318 (1981-02-01), Dostert et al.
patent: 4435415 (1984-03-01), Bourgery
patent: 4461773 (1984-07-01), Gregory
patent: 4476136 (1984-10-01), Dostert et al.
patent: 4517197 (1985-05-01), Ancher et al.
patent: 5171747 (1992-12-01), Jarreau et al.
patent: 5182296 (1993-01-01), Nakai
patent: 5254577 (1993-10-01), Carlson
patent: 5480899 (1996-01-01), Yano
Abstract (corresponding to FRA 2381037) (1977).
Chemistry Letters, 1979 pp. 1277-1278, Published by Chem. Society of Japan.
R. J. Wurtmann and J. A. Axelrod Biochem. Pharmac. 12, 1439-41.
Borgulya Janos
Bruderer Hans
Jakob-Roetne Roland
R over Stephan
Daus Donald G.
Hoffmann-La Roche Inc.
Johnston George W.
Silverman Robert A.
LandOfFree
Oxazolidinone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolidinone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolidinone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-562915